<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>348</billNumber>
    <createDate>2017-02-10T07:41:49Z</createDate>
    <updateDate>2020-09-28T22:44:28Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2017-02-09</introducedDate>
    <congress>115</congress>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-02-09T21:03:43Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Improving Access To Affordable Prescription Drugs Act</latestTitle>
        <congress>115</congress>
        <number>1776</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2017-04-05</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Improving Access To Affordable Prescription Drugs Act</latestTitle>
        <congress>115</congress>
        <number>771</number>
        <type>S</type>
        <latestAction>
          <actionDate>2017-03-29</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017</latestTitle>
        <congress>115</congress>
        <number>1688</number>
        <type>S</type>
        <latestAction>
          <actionDate>2017-08-01</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2017-02-09</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2017-02-09</actionDate>
        <links />
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>F000457</bioguideId>
        <fullName>Sen. Franken, Al [D-MN]</fullName>
        <firstName>Al</firstName>
        <middleName />
        <lastName>Franken</lastName>
        <party>D</party>
        <state>MN</state>
        <identifiers>
          <lisID>1969</lisID>
          <bioguideId>F000457</bioguideId>
          <gpoId>8339</gpoId>
        </identifiers>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>R000122</bioguideId>
        <fullName>Sen. Reed, Jack [D-RI]</fullName>
        <firstName>JOHN</firstName>
        <middleName>F.</middleName>
        <lastName>REED</lastName>
        <party>D</party>
        <state>RI</state>
        <identifiers>
          <lisID>949</lisID>
          <bioguideId>R000122</bioguideId>
          <gpoId>8272</gpoId>
        </identifiers>
        <sponsorshipDate>2017-02-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>B000944</bioguideId>
        <fullName>Sen. Brown, Sherrod [D-OH]</fullName>
        <firstName>Sherrod</firstName>
        <middleName />
        <lastName>Brown</lastName>
        <party>D</party>
        <state>OH</state>
        <identifiers>
          <lisID>136</lisID>
          <bioguideId>B000944</bioguideId>
          <gpoId>8309</gpoId>
        </identifiers>
        <sponsorshipDate>2017-02-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>G000555</bioguideId>
        <fullName>Sen. Gillibrand, Kirsten E. [D-NY]</fullName>
        <firstName>Kirsten</firstName>
        <middleName>E.</middleName>
        <lastName>Gillibrand</lastName>
        <party>D</party>
        <state>NY</state>
        <identifiers>
          <lisID>1866</lisID>
          <bioguideId>G000555</bioguideId>
          <gpoId>8336</gpoId>
        </identifiers>
        <sponsorshipDate>2017-03-29</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Cancer</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Public contracts and procurement</name>
          </item>
          <item>
            <name>Veterans' medical care</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2017-02-09</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2018-02-08T20:02:05Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><strong>Prescription Drug and Health Improvement Act of 2017</strong></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to negotiate lower prices on behalf of Medicare and Medicare Advantage (MA) beneficiaries for covered prescription drugs that the CMS deems appropriate for negotiation based on: (1) program and per-beneficiary spending, (2) unit price&nbsp;increases over the preceding years, (3) initial launch price,&nbsp;(4) availability of similarly effective alternative treatments, (5) status of the drug as a follow-on to previously approved drugs,&nbsp;and (6) any other criteria determined by the CMS.</p> <p>If, after a one year period, negotiations with respect to a covered prescription drug prove unsuccessful, the CMS shall establish a price for the drug that is equal to the lesser of the price paid by the Department of Veterans Affairs or the price paid by the four largest federal pharmaceutical-drug purchasers.</p> <p>The CMS may (but is not required to)&nbsp;negotiate lower prices on behalf of Medicare and MA beneficiaries for other covered prescription drugs.</p> <p>The Government Accountability Office must report to Congress on the CMS' negotiations.</p> <p>The Center for Medicare and Medicaid Innovation must test&nbsp;several specified&nbsp;models for negotiating drug and biological prices.</p>]]></text>
          <updateDate>2017-02-09T05:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Prescription Drug and Health Improvement Act of 2017</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>A bill to amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Prescription Drug and Health Improvement Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Prescription Drug and Health Improvement Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Prescription Drug and Health Improvement Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2017-02-09T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s348is/xml/BILLS-115s348is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2017-02-09</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

